Elevated serum levels of calprotectin (MRP8/MRP14) in patients with Behçet's disease and its association with disease activity and quality of life

References

• Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum 1998;27:197–217.
   PubMed Web of Science ®Google Scholar
• Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci, F Akkaya S, Telatar H, Zileli T. Vascular involvement in Behcet's disease. J Rheumatol 1992;19:402–10.
   PubMed Web of Science ®Google Scholar
• Kalayciyan A, Zouboulis C. An update on Behçet's disease. J Eur Acad Dermatol Venereol 2007;21:1–10.
   PubMed Web of Science ®Google Scholar
• Kwon SR, Lim MJ, Park SG, Moon YS, Park W. Decreased protein S activity is related to the disease activity of Behcet's disease. Rheumatol Int 2006;27:39–43.
   PubMed Web of Science ®Google Scholar
• Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426–33.
   PubMed Web of Science ®Google Scholar
• Sakane T. New perspective on Behçet's disease. Int Rev Immunol 1997;14:89–96.
   PubMedGoogle Scholar
• Sahin S, Akoğlu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996;55:128–33.
   PubMed Web of Science ®Google Scholar
• Rizzi R, Bruno S, Dammacco R. Behçet's disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997;27:225–32.
   PubMedGoogle Scholar
• Zouboulis CC, May T. Pathogenesis of Adamantiades- Behçet's disease. Med Microbiol Immunol 2003;192: 149–55.
   PubMed Web of Science ®Google Scholar
• Han EC, Cho SB, Ahn KJ, Oh SH, Kim J, Kim DS, Lee KH, Bang D. Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet's disease and its association with disease activity: a pilot study. Ann Dermatol 2011;23:313–20.
   PubMed Web of Science ®Google Scholar
• Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen, MA, Nacken, W, Foell D, van der Poll T, Sorg, C, Roth, J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin- induced shock. Nat Med 2007;13:1042–49.
   PubMed Web of Science ®Google Scholar
• Edgeworth J, Freemont P, Hogg N. Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14. Nature 1989;342:189–92.
   PubMed Web of Science ®Google Scholar
• Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003;60:569–80.
   PubMed Web of Science ®Google Scholar
• Frosch M, Strey A, Vogl T, Wulffraat Nm, Kuıs W, Sunderkotter C, Harms E, Sorg C, Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43:628–37.
   PubMed Web of Science ®Google Scholar
• Yen T, Harrison CA, Devery JM, Leong S, Iismaa SE, Yoshimura T, Geczy CL. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood 1997;90:4812–21.
   PubMed Web of Science ®Google Scholar
• Berntzen HB, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989;16:1416–20.
   PubMed Web of Science ®Google Scholar
• Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D, Foell D, Sorg C, Sunderkötter C, Roth J. Expression of myeloid-related protein 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2003; 48:2622–6.
   PubMed Web of Science ®Google Scholar
• Foell D, Roth J. Proinflammatory S100-proteins in arthritis and autoimmune disease. Arthritis Rheum 2004;50:3762–71.
   PubMed Web of Science ®Google Scholar
• Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, Watanabe K, Wanatabe S, Tsubata S, Uese K, Hashimoto I, Ichida F, Nakazawa M, Roth J, Miyawaki T. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J Am Coll Cardiol 2006;19;48: 1257–64.
   Google Scholar
• Robinson MJ, Tessier P, Poulsom R, Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 2002;277:3658–65.
   PubMed Web of Science ®Google Scholar
• Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001; 166:4678–88.
   PubMed Web of Science ®Google Scholar
• Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, Gerke V, Sorg C, Roth J. Myeloid-related protein 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005;105:2955– 62.
   PubMed Web of Science ®Google Scholar
• Viemann D, Barczyk K, Vogl T, Fischer U, Sunderkötter C, Schulze-Osthoff K, Roth J. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program Blood 2007;15;109:2453–60.
   Google Scholar
• Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733–8.
   PubMed Web of Science ®Google Scholar
• Vaos G, Kostakis ID, Zavras N, Chatzemichael A. The role of calprotectin in pediatric disease. Biomed Res Int 2013;2013:542363.
   PubMedGoogle Scholar
• Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet's Disease activity index. Rheumatol 2004;43:73–8.
   PubMed Web of Science ®Google Scholar
• Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H. Evaluation of the Turkish translation of a disease activity form for Behcets syndrome. Rheumatology 1999;38:734–6.
   PubMed Web of Science ®Google Scholar
• Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A 1981;15:221–9.
   PubMedGoogle Scholar
• Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T. The development and psychometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 2000; 23:31–8.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith PR. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Aydemir O, Guvenir T, Kuey L, Kultur S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Dergisi 1997;8:280–7.
   Google Scholar
• Baker RB. Smith EV, Osheik AS. Pathergy test. Pract Neurol 2011;11:301–2.
   PubMedGoogle Scholar
• Boyd JH, Kan B, Roberts H, Wang Y, Walley KR. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008;102:1239–46.
   PubMed Web of Science ®Google Scholar
• Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003;23:2564–76.
   PubMed Web of Science ®Google Scholar
• Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W, Werner S, Sorg C, Roth J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004;104:4260–8.
   PubMed Web of Science ®Google Scholar
• Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009;86:557–66.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Gabrielsen TO, Dale I, Muller F. Steinbakk M, Fagerhol MK. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995;371A:201–6.
   PubMedGoogle Scholar
• Eversole LR, Miyasaki KT, Christensen RE. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med 1993;22:303–7.
   PubMed Web of Science ®Google Scholar
• Schlegel Gómez R, Langer P, Pelka M, von den Driesch P, Johannessen AC, Simon M Jr. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol 1995;22:341–6.
   PubMed Web of Science ®Google Scholar
• Kido J, Nakamura T, Kido R, Ohishi K, Yamauchi N, Kataoka M, Nagata T. Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid. J Periodontal Res 1998;33:434–7.
   PubMed Web of Science ®Google Scholar
• Chan TK, Dick AD, Forrester JV, Herriot R. Antineutrophil cytoplasmic antibodies in chronic idiopathic intraocular inflammatory disease. Ocul Immunol Inflamm 1996;4: 83–90.
   PubMed Web of Science ®Google Scholar
• Akyol N, Değer O, Erdöl H, Gedik Y, Orem A, Imamoglu HI. The importance of plasma polymorphonuclear (PMN) elastase determination in patients with uveitis. Acta Ophthalmol Scand 1997;75:287–9.
   PubMedGoogle Scholar
• Olson JA, Forrester M, Cloheddy PA, Golden BE, Hettiot R, Forrester JV. Calprotectin is raised in endogenous posterior uveitis. Ocul Immunol Inflamm 1996;4:91–8.
   PubMed Web of Science ®Google Scholar
• Borman P, Tuncay F, Kocaoğlu S, Okumuş M, Güngör E, Ekşioğlu M. The subclinic autonomic dysfunction in patients with Behçet disease: an electrophysiological study. Clin Rheumatol 2012;31:41–7.
   PubMed Web of Science ®Google Scholar
• Haga HJ, Brun JG, Berntzen HB, Cervera R, Khamashta M, Hughes GR. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993;2:47–50.
   PubMed Web of Science ®Google Scholar
• Foell D, Hernández-Rodríguez J, Sánchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204:311–6.
   PubMed Web of Science ®Google Scholar
• Engin B, Güner OR. Negative evaluation of a pathergy test in hepatitis B surface antigen carriers. J Dermatol 2006;33:547–9.
   PubMed Web of Science ®Google Scholar
• Oktayoglu P, Bozkurt M, Mete N, Caglayan M, Em S, Nas K. Elevated serum levels of calprotectin (myeloid- related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life. J Investig Med 2014;62:880–4.
   PubMed Web of Science ®Google Scholar
• Tanriverdi N, Taskıntuna Y, Duru Ç, Ozdal P, Ortaç S, Firat E. Health-related quality of life in Behçet patients with ocular involvement. Jpn J Ophthalmol 2003;47:85–92.
   PubMed Web of Science ®Google Scholar
• Bodur H, Borman P, Ozdemir Y, Atan C, Kural G. Quality of life and life satisfaction in patients with behcet's disease: relationship with disease activity. Clin Rheumatol 2006;25:329–33.
   PubMed Web of Science ®Google Scholar
• Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R. Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors. Clin Rheumatol 2006;25:524–31.
   PubMed Web of Science ®Google Scholar